Anoro Ellipta Approved for COPD
WEDNESDAY, Dec. 18, 2013 (HealthDay News) -- Anoro Ellipta (umeclidinium and vilanterol inhalation powder) has been approved by the U.S. Food and Drug Administration for once-daily treatment of chronic obstructive pulmonary disease (COPD).
COPD, an umbrella term that includes the lung diseases bronchitis and emphysema, is a progressive condition that interferes with breathing. Symptoms may include chest tightness, chronic cough and overproduction of phlegm. It's the third-leading cause of death in the United States, the FDA said in a news release.
Anoro Ellipta, a combination of two approved medications, relaxes the lung airways to help breathing. The drug's safety and effectiveness were evaluated in clinical trials involving more than 2,400 people diagnosed with COPD.
The drug's label includes a warning that users have an increased risk of asthma-related death. However, the medication has not been evaluated in people with asthma, nor should it be taken as a treatment for asthma or for sudden breathing problems, the agency stressed.
Potential serious side effects of the new drug include narrowing of the respiratory airways, cardiovascular problems, glaucoma and worsening urinary retention. The most common side effects include sore throat, sinus infection, respiratory tract infection, constipation, diarrhea, extremity pain and muscle spasms.
Anoro Ellipta is produced by GlaxoSmithKline, based in Research Triangle Park, N.C.
More information
The U.S. National Library of Medicine has more about COPD.
Related Articles
Search Allergy Articles
Healthy, Diverse Infant Microbiome Could Shield Kids From Asthma
What Is Chronic Sinusitis, and How Is it Treated?
Back-to-School Tips on Preventing Asthma, Allergy Flares in Kids
Seniors, Here Are the Meds That Can Harm Your Driving Skills
FDA Panel Recommends Approval of First Nasal Spray to Combat Severe Allergy Attacks
Roadside Trees, Bushes Are Cutting Air Pollution, Study Finds
Dirty Air Increasingly Affects Minority Communities
Smoke From Wildfires Is Especially Tough If You Have Asthma. Here’s How to Protect Yourself
American Air Is Getting Cleaner, But Benefits Aren't Reaching All
FDA Expands Use of Asthma Med Xolair to Treat Food Allergies